From left, partners Jeff Hammel, global co-chair of securities litigation and professional liability practice, Jamie Wine, former global chair of litigation and trial department, and Andrew Clubok, global co-chair of securities litigation and professional liability practice (Photo by David Handschuh, NYLJ)
What are some of the department’s most satisfying successes of the past year and why? Only a small handful of securities cases (out of the thousands filed in the past 30 years) have gone all the way to a trial verdict, and Latham is one of the few major law firms to have taken not just one, but several of these cases through trial. Latham recently secured a jury trial win for Puma Biotechnology in the first federal securities class action to reach a verdict in nearly 10 years. In the same period, a Latham team represented UBS Securities before the New York Supreme Court in a high-profile lawsuit against Highland Capital.
Clients consistently turn to Latham to try their bet-the-company cases, but it is extremely rare to have one trial in this space in a single calendar year, let alone two. And Latham is gearing up for a third trial this December, on behalf of Walworth, the investment vehicle for the Ryan family, which is seeking hundreds of millions for alleged fraud in connection with the buyback of shares by Mu Sigma.
